JP2017517543A - ウイルス性皮膚疾患の治療 - Google Patents

ウイルス性皮膚疾患の治療 Download PDF

Info

Publication number
JP2017517543A
JP2017517543A JP2016572431A JP2016572431A JP2017517543A JP 2017517543 A JP2017517543 A JP 2017517543A JP 2016572431 A JP2016572431 A JP 2016572431A JP 2016572431 A JP2016572431 A JP 2016572431A JP 2017517543 A JP2017517543 A JP 2017517543A
Authority
JP
Japan
Prior art keywords
extract
herpes
treatment
viral
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016572431A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017517543A5 (enExample
Inventor
アングル，エリカ，エヌ．
Original Assignee
イクセラ，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イクセラ，インコーポレイテッド filed Critical イクセラ，インコーポレイテッド
Publication of JP2017517543A publication Critical patent/JP2017517543A/ja
Publication of JP2017517543A5 publication Critical patent/JP2017517543A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2016572431A 2014-06-11 2015-06-11 ウイルス性皮膚疾患の治療 Pending JP2017517543A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462010860P 2014-06-11 2014-06-11
US62/010,860 2014-06-11
PCT/US2015/035384 WO2015191891A1 (en) 2014-06-11 2015-06-11 Treatment of virus-based diseases of the skin

Publications (2)

Publication Number Publication Date
JP2017517543A true JP2017517543A (ja) 2017-06-29
JP2017517543A5 JP2017517543A5 (enExample) 2018-07-19

Family

ID=54834337

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016572431A Pending JP2017517543A (ja) 2014-06-11 2015-06-11 ウイルス性皮膚疾患の治療

Country Status (6)

Country Link
US (3) US10034908B2 (enExample)
EP (1) EP3154637A4 (enExample)
JP (1) JP2017517543A (enExample)
CN (1) CN106457000A (enExample)
CA (1) CA2951881C (enExample)
WO (1) WO2015191891A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3018294A1 (en) * 2016-06-01 2017-12-07 Excision Biotherapeutics, Inc. Compositions and methods of treatment for lytic and lysogenic viruses
CN107184886B (zh) 2017-05-16 2018-06-19 贾洪章 抗病毒中药组合物及其制备方法和用途
US11065289B1 (en) 2020-12-21 2021-07-20 Elena Sanchez Alonso Substance and method for the treatment of poxvirus
US12485153B1 (en) 2021-06-16 2025-12-02 Elena Sanchez Alonso Substance for the treatment of poxvirus

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11103832A (ja) * 1997-09-25 1999-04-20 Sho Ki タンポポ茶葉の製造方法、タンポポ茶葉、抗ウイルス剤
CN101023972A (zh) * 2007-03-26 2007-08-29 赵昱 蒲公英中酚酸类有效部位治疗口腔溃疡的用途
CN102961521A (zh) * 2012-12-11 2013-03-13 王正艳 一种治疗单纯疱疹病毒性角膜炎的药物
CN103800485A (zh) * 2014-03-12 2014-05-21 马丽 一种治疗单纯疱疹病毒性角膜炎的中药制剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1246029C (zh) 2002-05-28 2006-03-22 杨毓龙 治疗带状疱疹的药物
CN100998657A (zh) * 2006-12-28 2007-07-18 江蕾 一种治疗带状疱疹的内服中药
CN101181366B (zh) * 2007-11-26 2010-06-16 仲海崑 一种内服加外用治疗带状疱疹的中药组合物
CN101391044A (zh) * 2008-11-13 2009-03-25 牛德兴 一种治疗带状疱疹、单纯疱疹等病毒性疾病的外用中药及其制备方法
US8609156B2 (en) * 2009-10-05 2013-12-17 Protanza Corporation Compositions and methods of treatment that include plant extracts
CN102068611B (zh) * 2009-11-19 2012-06-06 谢菊荣 一种治疗缠腰蛇的外用膏

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11103832A (ja) * 1997-09-25 1999-04-20 Sho Ki タンポポ茶葉の製造方法、タンポポ茶葉、抗ウイルス剤
CN101023972A (zh) * 2007-03-26 2007-08-29 赵昱 蒲公英中酚酸类有效部位治疗口腔溃疡的用途
CN102961521A (zh) * 2012-12-11 2013-03-13 王正艳 一种治疗单纯疱疹病毒性角膜炎的药物
CN103800485A (zh) * 2014-03-12 2014-05-21 马丽 一种治疗单纯疱疹病毒性角膜炎的中药制剂

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中西医結合雑誌, vol. 10, no. 1, JPN6019008694, 1990, pages 39 - 41, ISSN: 0004189393 *
日本臨床, vol. 70, no. 4, JPN6019008693, 2012, pages 558 - 563, ISSN: 0004189394 *

Also Published As

Publication number Publication date
CA2951881A1 (en) 2015-12-17
EP3154637A1 (en) 2017-04-19
US20150359833A1 (en) 2015-12-17
CN106457000A (zh) 2017-02-22
US10213468B2 (en) 2019-02-26
CA2951881C (en) 2020-12-29
US10034908B2 (en) 2018-07-31
US10220066B2 (en) 2019-03-05
WO2015191891A1 (en) 2015-12-17
EP3154637A4 (en) 2018-02-07
US20180296619A1 (en) 2018-10-18
US20180296620A1 (en) 2018-10-18

Similar Documents

Publication Publication Date Title
Schiffer et al. Rapid host immune response and viral dynamics in herpes simplex virus-2 infection
Mustafa et al. Herpes simplex virus infections, Pathophysiology and Management
Cohen et al. Recent advances in varicella-zoster virus infection
Sluka et al. Acid‐sensing ion channel 3 deficiency increases inflammation but decreases pain behavior in murine arthritis
Klimas et al. Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions
US10213468B2 (en) Treatment of virus-based diseases of the skin
Stiles Feline herpesvirus
Wang et al. Glutamine supplementation suppresses herpes simplex virus reactivation
Staikuniene et al. Long-term valacyclovir treatment and immune modulation for Herpes-associated erythema multiforme
Stiles Feline herpesvirus
Breier et al. Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study
Eleftheriou et al. Effect of amygdaloid lesions on plasma and pituitary levels of luteinizing hormone
Lachmann Herpes simplex virus latency
Shinde et al. Revisiting the therapeutic potential of homeopathic medicine Rhus Tox for herpes simplex virus and inflammatory conditions
Mundy et al. Effects of cyclophosphamide myelosuppression in adult dogs with latent canine herpesvirus-1 infection
WO2001045727A2 (en) Stabilized veterinary compositions comprising more than one antiviral agent
Verma et al. Therapeutic effects of spironolactone on a collagen-induced arthritis model of rheumatoid arthritis
Sen et al. Retinoic Acid Neutralizes the Effects of Herpes Simplex Virus Type 1-Infected Cell Protein 0 (ICP0) in Retinal Pigment Epithelial Cells
Al-Khayri et al. Inhibitory effect on acute herpes and prevention of postherpetic neuralgia in herpes simplex virus-1-infected mice using a plant extract Ricinus communis
KR101876019B1 (ko) 엔-메탄노카르바티미딘을 이용한 대상포진의 치료방법
WO2023201882A1 (zh) 香菇多糖在治疗新型冠状病毒感染中的应用
Bhattacharya et al. Piperazine inhibits Anatid herpesvirus-1 infection by possible modulation of host cytokines
Whitley et al. present, and future [version 1; peer review: 2 approved]
JPH08268901A (ja) ヘルペスウイルスに起因するウイルス感染症再発予防剤
CHANY Interferons and sarcolectins in coordinated cell growth: reconversion of malignant cells to a nononcogenic status

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161228

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180607

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180607

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190213

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190319

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190619

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190814

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200114